Qualitative or quantitative defects of alpha-actin

Qualitative or quantitative defects of alpha-actin (Orphanet code 209059) is a grouping term that encompasses a set of rare genetic conditions caused by mutations in the ACTA1 gene, which encodes skeletal muscle alpha-actin. Alpha-actin is a major structural protein of the thin filament in skeletal muscle and is essential for normal muscle contraction. Mutations in ACTA1 can lead to either qualitative defects (production of a structurally abnormal protein) or quantitative defects (reduced or absent production of the protein), both of which impair skeletal muscle function. These defects primarily affect the skeletal muscular system and can manifest as several distinct myopathies, including nemaline myopathy (the most common association), actin myopathy, intranuclear rod myopathy, and congenital fiber-type disproportion. Clinical features vary widely in severity but commonly include generalized muscle weakness (often predominantly proximal), hypotonia, respiratory insufficiency, feeding difficulties, and delayed motor milestones. In severe neonatal forms, profound weakness and respiratory failure may be life-threatening. Milder forms may present in childhood or even adulthood with slowly progressive weakness and exercise intolerance. Facial weakness and skeletal deformities such as scoliosis and chest wall abnormalities may also occur. There is currently no cure or disease-specific therapy for ACTA1-related myopathies. Management is supportive and multidisciplinary, focusing on respiratory support (including non-invasive or invasive ventilation), nutritional support, physical therapy, and orthopedic interventions as needed. Ongoing research into gene therapy and other molecular approaches offers hope for future targeted treatments. Genetic counseling is recommended for affected families.

Common questions about Qualitative or quantitative defects of alpha-actin